XSHG
600389
Market cap1.72bUSD
Feb 24, Last price
27.52CNY
1Q
28.72%
Jan 2017
102.20%
IPO
397.65%
Name
Nantong Jiangshan Agrochemical & Chemicals Co Ltd
Chart & Performance
P/E
52.81
P/S
2.18
EPS
0.52
Div Yield, %
2.00%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
2.58%
Revenues
5.43b
+6.80%
Net income
224m
-20.69%
CFO
347m
-54.90%
Dividend
Oct 17, 20250.45 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. produces and markets agrochemicals, resins, chlorine-caustic sodium, and fine chemicals in China. The company offers herbicides, including glyphosate, alachlor, acetochlor, butachlor, butachlor+propanil, quizalofop-p-ethyl, and metolachlor; insecticides, such as dichlorvos, trichlorphon, diazion, nitenpyram, and imidaclothiz; and fungicides comprising prochloraz and prochloraz manganese complex products. It also provides intermediate products consisting of chloral, phosphorus acid, trimethyl and dimethyl phosphite, phosphorus trichloride, PMIDA, paraformaldehyde, and chlormethane; microporous insulating board and nanometer aluminum oxide materials; and flame retardant products. The company also exports its products to 40 countries and regions in Asia, Europe, the United States, and Africa. Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. is based in Nantong, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||